Pender & Associates Ltd (FINN Partners )

Lobbying Organisation Pender & Associates Ltd

Date published 20 Sep, 2017

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2017 to 31 Aug, 2017

Specific Details Introduction of National Medicines Policy, National Medicines Office, and introduction of biosimilars consultation

Intended results Policy change to improve delivery of medicines in Ireland and encourage use of biosimilars

Name of person primarily responsible for lobbying on this activity Rosemary Hennigan and Amanda Glancy

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name Medicines for Ireland

CRO number (if applicable)

Company address 50 Upper Mount Street, Dublin 2

Main business or activity

Company website

Contact email address info@medicinesforireland.ie

Contact phone number 01-637 1777

Contact address

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Email (2-5)

Request for parliamentary question to get time frame for introduction of biosimilar consultation

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Bernard Durkan TD (Dáil Éireann, the Oireachtas)